Annual Accounts Payable
$2.59 M
-$217.30 K-7.75%
31 December 2023
Summary:
Sunshine Biopharma annual accounts payable is currently $2.59 million, with the most recent change of -$217.30 thousand (-7.75%) on 31 December 2023. During the last 3 years, it has risen by +$2.54 million (+5926.81%). SBFM annual accounts payable is now -99.99% below its all-time high of $27.20 billion, reached on 01 December 2002.SBFM Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Payable
$4.16 M
-$772.80 K-15.68%
30 September 2024
Summary:
Sunshine Biopharma quarterly accounts payable is currently $4.16 million, with the most recent change of -$772.80 thousand (-15.68%) on 30 September 2024. Over the past year, it has increased by +$1.57 million (+60.79%). SBFM quarterly accounts payable is now -15.68% below its all-time high of $4.93 million, reached on 30 June 2024.SBFM Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SBFM Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | +60.8% |
| 3 y3 years | +5926.8% | +9590.7% |
| 5 y5 years | +2568.2% | +4190.3% |
SBFM Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -7.8% | +5926.8% | -15.7% | +9590.7% |
| 5 y | 5 years | -7.8% | +5926.8% | -15.7% | +9590.7% |
| alltime | all time | -100.0% | >+9999.0% | -15.7% |
Sunshine Biopharma Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $4.16 M(-15.7%) |
| June 2024 | - | $4.93 M(+36.4%) |
| Mar 2024 | - | $3.62 M(+39.8%) |
| Dec 2023 | $2.59 M(-7.8%) | $2.59 M(+16.4%) |
| Sept 2023 | - | $2.22 M(+26.2%) |
| June 2023 | - | $1.76 M(-35.7%) |
| Mar 2023 | - | $2.74 M(-2.4%) |
| Dec 2022 | $2.80 M(+6433.3%) | $2.80 M(+483.7%) |
| Sept 2022 | - | $480.20 K(+358.6%) |
| June 2022 | - | $104.70 K(+10.0%) |
| Mar 2022 | - | $95.20 K(+121.9%) |
| Dec 2021 | $42.90 K(-31.8%) | - |
| Dec 2021 | - | $42.90 K(-24.3%) |
| Sept 2021 | - | $56.70 K(-45.1%) |
| June 2021 | - | $103.20 K(-30.6%) |
| Mar 2021 | - | $148.60 K(+136.2%) |
| Dec 2020 | $62.90 K(-35.1%) | $62.90 K(+9.0%) |
| Sept 2020 | - | $57.70 K(-35.8%) |
| June 2020 | - | $89.90 K(-8.3%) |
| Mar 2020 | - | $98.00 K(+1.1%) |
| Dec 2019 | $96.90 K(-16.3%) | $96.90 K(+49.5%) |
| Sept 2019 | - | $64.80 K(-23.2%) |
| June 2019 | - | $84.40 K(-39.8%) |
| Mar 2019 | - | $140.30 K(+21.2%) |
| Dec 2018 | $115.80 K(+500.0%) | $115.80 K(+10.3%) |
| Sept 2018 | - | $105.00 K(-24.5%) |
| June 2018 | - | $139.00 K(+22.6%) |
| Mar 2018 | - | $113.40 K(+487.6%) |
| Dec 2017 | $19.30 K(-31.3%) | $19.30 K(+59.5%) |
| Sept 2017 | - | $12.10 K(-65.1%) |
| June 2017 | - | $34.70 K(+23.9%) |
| Mar 2017 | - | $28.00 K(-0.4%) |
| Dec 2016 | $28.10 K(-39.7%) | $28.10 K(+45.6%) |
| Sept 2016 | - | $19.30 K(-45.9%) |
| June 2016 | - | $35.70 K(+45.7%) |
| Mar 2016 | - | $24.50 K(-47.4%) |
| Dec 2015 | $46.60 K | $46.60 K(+34.7%) |
| Sept 2015 | - | $34.60 K(-3.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2015 | - | $35.70 K(-23.4%) |
| Mar 2015 | - | $46.60 K(+33.9%) |
| Dec 2014 | $34.80 K(+46.2%) | $34.80 K(-32.2%) |
| Sept 2014 | - | $51.30 K(-45.4%) |
| June 2014 | - | $93.90 K(+89.7%) |
| Mar 2014 | - | $49.50 K(+108.0%) |
| Dec 2013 | $23.80 K(+3866.7%) | $23.80 K(+170.5%) |
| Sept 2013 | - | $8800.00(+2833.3%) |
| June 2013 | - | $300.00(-96.4%) |
| Mar 2013 | - | $8300.00(+1283.3%) |
| Dec 2012 | $600.00(-82.4%) | $600.00(-62.5%) |
| Sept 2012 | - | $1600.00(-90.3%) |
| June 2012 | - | $16.50 K(+106.3%) |
| Mar 2012 | - | $8000.00(+135.3%) |
| Dec 2011 | $3400.00(-70.2%) | $3400.00(-24.4%) |
| Sept 2011 | - | $4500.00(>+9900.0%) |
| June 2011 | - | $0.00(-100.0%) |
| Mar 2011 | - | $300.00(-97.4%) |
| Dec 2010 | $11.40 K(-20.3%) | $11.40 K(-52.1%) |
| Sept 2010 | - | $23.80 K(+42.5%) |
| June 2010 | - | $16.70 K(+4.4%) |
| Mar 2010 | - | $16.00 K(>+9900.0%) |
| Dec 2009 | $14.30 K(+43.0%) | - |
| Oct 2009 | - | $0.00(-100.0%) |
| July 2009 | $10.00 K(+92.3%) | $10.00 K(+58.7%) |
| Apr 2009 | - | $6300.00(+6.8%) |
| Jan 2009 | - | $5900.00(+59.5%) |
| Oct 2008 | - | $3700.00(-28.8%) |
| July 2008 | $5200.00(+246.7%) | $5200.00(+40.5%) |
| Apr 2008 | - | $3700.00(+48.0%) |
| Jan 2008 | - | $2500.00(-24.2%) |
| Oct 2007 | - | $3300.00 |
| July 2007 | $1500.00(-100.0%) | - |
| Dec 2003 | $26.42 B(-2.9%) | - |
| Dec 2002 | $27.20 B(+44.1%) | - |
| Dec 2001 | $18.88 B(-29.0%) | - |
| Dec 2000 | $26.61 B(+47.0%) | - |
| Dec 1999 | $18.11 B(+14.1%) | - |
| Dec 1998 | $15.88 B | - |
FAQ
- What is Sunshine Biopharma annual accounts payable?
- What is the all time high annual accounts payable for Sunshine Biopharma?
- What is Sunshine Biopharma quarterly accounts payable?
- What is the all time high quarterly accounts payable for Sunshine Biopharma?
- What is Sunshine Biopharma quarterly accounts payable year-on-year change?
What is Sunshine Biopharma annual accounts payable?
The current annual accounts payable of SBFM is $2.59 M
What is the all time high annual accounts payable for Sunshine Biopharma?
Sunshine Biopharma all-time high annual accounts payable is $27.20 B
What is Sunshine Biopharma quarterly accounts payable?
The current quarterly accounts payable of SBFM is $4.16 M
What is the all time high quarterly accounts payable for Sunshine Biopharma?
Sunshine Biopharma all-time high quarterly accounts payable is $4.93 M
What is Sunshine Biopharma quarterly accounts payable year-on-year change?
Over the past year, SBFM quarterly accounts payable has changed by +$1.57 M (+60.79%)